Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ARHGAP33 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | FKBP6 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | LYN | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
mRNA | GRM4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | HSF1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | RANBP9 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | TMEM38B | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | VAC14 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | GADL1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | STAG3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |